Craig Gerrand
Overview
Explore the profile of Craig Gerrand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
790
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taylor R, Purnell S, Hocking S, Windsor R, Gerrand C, Jenney M, et al.
J Patient Rep Outcomes
. 2025 Mar;
9(1):30.
PMID: 40067547
Purpose: Sarcomas account for approximately 10-15% of all cancer in children aged ≤ 16. Poorer health-related quality of life (HRQoL) is recorded in comparison to other cancers; however, these studies...
2.
Sambri A, Campanacci D, Pala E, Smolle M, Donati D, van de Sande M, et al.
Bone Joint J
. 2025 Jan;
107-B(2):253-260.
PMID: 39889756
Aims: The aim of this study was to assess the incidence of reinfection in patients after two-stage revision of an infected megaprosthesis (MPR) implanted after resection of a bone tumour....
3.
Jeys L, Morris G, Kurisunkal V, Botello E, Boyle R, Ebeid W, et al.
Bone Joint J
. 2025 Jan;
107-B(2):246-252.
PMID: 39889743
Aims: The Birmingham Orthopaedic Oncology Meeting (BOOM), held in January 2024, convened 309 delegates from 53 countries to discuss and refine 21 consensus statements on the optimal management of chondrosarcoma....
4.
De Vega B, Dutta A, Mumtaz A, Schroeder B, Gerrand C, Boyd A, et al.
Front Bioeng Biotechnol
. 2025 Jan;
12():1473777.
PMID: 39834640
Purpose: The study conducts a comparative analysis between two prominent methods for fabricating composites for bone scaffolds-the (solid) solvent method and the solvent-free (melting) method. While previous research has explored...
5.
McCarthy A, Dean L, Artis D, Green L, Khouri M, Gerrand C, et al.
Disabil Rehabil
. 2024 Nov;
:1-14.
PMID: 39563092
Background And Aims: Clinical practice guidelines for rehabilitation in musculoskeletal oncology are lacking. Guidelines should include recommendation statements aimed at optimising care to enhance recovery and quality of life. The...
6.
Gerrand C, Amary F, Anwar H, Brennan B, Dileo P, Kalkat M, et al.
Br J Cancer
. 2024 Nov;
132(1):32-48.
PMID: 39550489
This document is an update of the British Sarcoma Group guidelines (2016) and provides a reference standard for the clinical care of UK patients with primary malignant bone tumours (PMBT)...
7.
Gamie Z, Krippner-Heidenreich A, Gerrand C, Rankin K
Front Mol Biosci
. 2024 Sep;
11:1384795.
PMID: 39286782
Background: Death Receptor 5 (DR5) is expressed on the surface of primary bone and soft tissue sarcoma cells, and its activation induces cell death primarily through apoptosis. The combination of...
8.
Childs A, Gerrand C, Brennan B, Young R, Rankin K, Parry M, et al.
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001413
There has been little change to the standard treatment for osteosarcoma (OS) over the last 25 years and there is an unmet need to identify new biomarkers and novel therapeutic...
9.
Green D, Ewijk R, Tirtei E, Andreou D, Baecklund F, Baumhoer D, et al.
Clin Cancer Res
. 2024 Jun;
30(16):3395-3406.
PMID: 38869831
Osteosarcoma and Ewing sarcoma are bone tumors mostly diagnosed in children, adolescents, and young adults. Despite multimodal therapy, morbidity is high and survival rates remain low, especially in the metastatic...
10.
Furtado S, Galna B, Godfrey A, Rochester L, Gerrand C
PLoS One
. 2024 Mar;
19(3):e0300351.
PMID: 38547229
Background: Physical limitations are frequent and debilitating after sarcoma treatment. Markerless motion capture (MMC) could measure these limitations. Historically expensive cumbersome systems have posed barriers to clinical translation. Research Question:...